Autopsy report · NCT05948540
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Cause of deathStaffing, sites or logistics
“The trial has been temporarily suspended due to administrative issues”
Life of this trial
- Registered 4 months before it started.
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Global Coalition for Adaptive Research
- Sponsor type
- University, hospital or other
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- Intervention C Daridorexant; Intervention C Placebo
- Participants
- 200 (planned, not actual)
- Sites
- 9
- Countries
- United States
Trials that died the same way
- Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
“Trial has been suspended due to lack of resource and staff” - The Dose Finding Study of DAOIB Added to tDCS for AD
“The trial was suspended due to the budget issue” - Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
“The trial was suspended due to the inability to enroll qualified participants” - A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
“Trial was stopped due to difficult enrolment” - BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
“Company was sold and clinical trial was suspended then teminated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.